Leading the way to a cure

Lupus Research Update: 2013 Volume 2

Volume 2, 2013 | In This Issue

Lupus Clinical Trials - People Advancing Science >
Insights into Clinical Trials - One Doctor's Perspective >
Faces of Lupus - Transforming Personal Loss into Hope for Others >
Lupus News Corner >

Lupus News Corner

Collaborating For a Cure

Sharing Results and Sparking Ideas

Attendees of this year's ALR Collaborative Meeting on June 3rd and 4th were taken on a fascinating journey to the inner workings of the body — glimpses into the amazing complexity of the human cell.

Twenty-three investigators who are currently being funded through the ALR freely shared their experiences in formal presentations — both the challenges and successes — with colleagues. Each enlightening presentation was followed by a Q&A period, which allowed scientists in the audience to probe into new findings. Also, a poster session presenting the work of 17 investigators, currently being funded by the ALR, was held over the course of the meeting.

The diversity of topics covered illustrate the ALR's interest in funding initiatives that look to garner clues to the genetic underpinnings of the disease from many angles. "Distinguishing therapeutic targets … suppressing lupus with peptides … reprogramming cells to reduce disease severity are just a sampling of the many ideas that were shared at our Collaborative Meeting," said ALR President, Kenneth M. Farber. "And keeping colleagues informed of developments, changes, and breakthroughs is one truly important way to speed scientific discovery."

The ALR thanks Amgen, Eli Lilly and EMD Serono for their generous support of the ALR's Annual Scientific Collaborative Meeting.

Corporate Leaders Convene

On the morning of June 4th, the ALR held the inaugural meeting of its Corporate Leadership Circle to bring together corporations and pharmaceutical companies that share the organization's interest to speedily find new therapeutic agents and ultimately a cure for lupus.

The ALR's aim is to help this community understand our priorities to fund the most rigorous lupus research of the world's brightest scientists — while we foster dialogues to illuminate mutual goals.

The ALR thanks the following inaugural members for being a part of this important effort: Eli Lilly, EMD Serono, GlaxoSmithKline and Pfizer.

Ultimately, the ALR's interest is to make more treatment choices available to people with lupus — and we applaud the deep commitment of our Corporate Leadership Circle to propel lupus research toward a cure.

Upcoming Events

  • Jets Kickoff Luncheon
    Cipriani Wall Street, New York
    August 28th

  • Inaugural Multicultural Outreach Breakfast
    Museum of Art & Design, New York
    September 17th

  • Jets Lupus Awareness Day
    Metlife Stadium, New Jersey
    October 20th

  • 2013 Annual Gala Celebration
    Mandarin Oriental, New York
    December 4th

  • Walk With Us to Cure Lupus - Fall Season
    San Francisco, Justin Herman Plaza, September 21st
    Atlanta, Centennial Olympic Park, September 21st
    Dallas, Bachman Lake Park, October 5th
    Washington, DC, National Mall, October 12th
    Chicago, Diversey Harbor, October 19th
    New York City, Intrepid Sea, Air and Space Museum, October 19th
    Kansas City, T Bones Baseball Stadium, November 2nd
    Los Angeles, Rose Bowl, November 16th
    Connecticut, Nolan Athletic Complex, Date TBD

1.5 million

people in the U.S. have Lupus.

172 million

dollars committed to lupus research by the Lupus Research Alliance.

We're walking across the United States to raise awareness and funds for lupus research.


Show your support by visiting the Lupus Research Alliance online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Blackbaud
nonprofit software